Centre for Dengue Research, Department of Immunology and Molecular Medicine, University of Sri Jayewardenepura, Nugegoda 10250, Sri Lanka.
MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX1 4BH, UK.
Viruses. 2021 May 24;13(6):972. doi: 10.3390/v13060972.
Cross-reactive T cell immunity to seasonal coronaviruses (HCoVs) may lead to immunopathology or protection during SARS-CoV2 infection. To understand the influence of cross-reactive T cell responses, we used IEDB (Immune epitope database) and NetMHCpan (ver. 4.1) to identify candidate CD8 T cell epitopes, restricted through HLA-A and B alleles. Conservation analysis was carried out for these epitopes with HCoVs, OC43, HKU1, and NL63. 12/18 the candidate CD8 T cell epitopes (binding score of ≥0.90), which had a high degree of homology (>75%) with the other three HCoVs were within the NSP12 and NSP13 proteins. They were predicted to be restricted through HLA-A2402, HLA-A201, HLA-A206, and HLA-B alleles B3501. Thirty-one candidate CD8 T cell epitopes that were specific to SARS-CoV2 virus (<25% homology with other HCoVs) were predominantly identified within the structural proteins (spike, envelop, membrane, and nucleocapsid) and the NSP1, NSP2, and NSP3. They were predominantly restricted through HLA-B3501 (6/31), HLA-B4001 (6/31), HLA-B4403 (7/31), and HLA-A2402 (8/31). It would be crucial to understand T cell responses that associate with protection, and the differences in the functionality and phenotype of epitope specific T cell responses, presented through different HLA alleles common in different geographical groups, to understand disease pathogenesis.
针对季节性冠状病毒(HCoV)的交叉反应性 T 细胞免疫可能导致 SARS-CoV2 感染期间的免疫病理或保护。为了了解交叉反应性 T 细胞反应的影响,我们使用 IEDB(免疫表位数据库)和 NetMHCpan(版本 4.1)来鉴定受 HLA-A 和 B 等位基因限制的候选 CD8 T 细胞表位。对这些表位与 HCoV、OC43、HKU1 和 NL63 进行了保守性分析。共有 12/18 候选 CD8 T 细胞表位(结合评分≥0.90)与其他三种 HCoV 具有高度同源性(>75%),位于 NSP12 和 NSP13 蛋白内。它们被预测受 HLA-A2402、HLA-A201、HLA-A206 和 HLA-B 等位基因 B3501 限制。31 个候选 SARS-CoV2 病毒特异性 CD8 T 细胞表位(与其他 HCoV 的同源性<25%)主要位于结构蛋白(刺突、包膜、膜和核衣壳)和 NSP1、NSP2 和 NSP3 内。它们主要受 HLA-B3501(6/31)、HLA-B4001(6/31)、HLA-B4403(7/31)和 HLA-A2402(8/31)限制。了解与保护相关的 T 细胞反应以及不同 HLA 等位基因普遍存在于不同地理群体中,从而了解疾病发病机制的不同功能和表型的表位特异性 T 细胞反应之间的差异非常重要。